IL141064A0 - Tnf-derived peptides for use in treating oedema - Google Patents

Tnf-derived peptides for use in treating oedema

Info

Publication number
IL141064A0
IL141064A0 IL14106499A IL14106499A IL141064A0 IL 141064 A0 IL141064 A0 IL 141064A0 IL 14106499 A IL14106499 A IL 14106499A IL 14106499 A IL14106499 A IL 14106499A IL 141064 A0 IL141064 A0 IL 141064A0
Authority
IL
Israel
Prior art keywords
tnf
oedema
alpha
present
derived peptides
Prior art date
Application number
IL14106499A
Other languages
English (en)
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of IL141064A0 publication Critical patent/IL141064A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL14106499A 1998-08-14 1999-08-10 Tnf-derived peptides for use in treating oedema IL141064A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP98870180 1998-08-14
EP98870198 1998-09-18
EP98870222 1998-10-21
PCT/EP1999/005806 WO2000009149A1 (fr) 1998-08-14 1999-08-10 Peptides derives du tnf utilises dans le traitement des oedemes

Publications (1)

Publication Number Publication Date
IL141064A0 true IL141064A0 (en) 2002-02-10

Family

ID=27239778

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14106499A IL141064A0 (en) 1998-08-14 1999-08-10 Tnf-derived peptides for use in treating oedema
IL141064A IL141064A (en) 1998-08-14 2001-01-24 Use of tnf-derived peptides for the manufacture of a medicament for treating oedema

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL141064A IL141064A (en) 1998-08-14 2001-01-24 Use of tnf-derived peptides for the manufacture of a medicament for treating oedema

Country Status (21)

Country Link
US (2) US20030105021A1 (fr)
EP (3) EP1247531B1 (fr)
JP (1) JP4542266B2 (fr)
CN (1) CN1181886C (fr)
AT (2) ATE395072T1 (fr)
AU (1) AU764992B2 (fr)
BR (1) BR9912899A (fr)
CA (1) CA2334941C (fr)
CZ (1) CZ302862B6 (fr)
DE (2) DE69938743D1 (fr)
DK (1) DK1264599T3 (fr)
ES (1) ES2296872T3 (fr)
HK (1) HK1051805A1 (fr)
HU (1) HU227661B1 (fr)
IL (2) IL141064A0 (fr)
NZ (1) NZ509604A (fr)
PL (1) PL203706B1 (fr)
PT (1) PT1264599E (fr)
TR (1) TR200100338T2 (fr)
WO (1) WO2000009149A1 (fr)
ZA (1) ZA200100656B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1181886C (zh) 1998-08-14 2004-12-29 基因创新有限公司 Tnf来源的肽在治疗水肿中的应用
US8236750B2 (en) 2004-08-06 2012-08-07 Nycomed Gmbh Composition comprising a pulmonary surfactant and a TNF-derived peptide
EP2009023A1 (fr) * 2007-06-04 2008-12-31 Rentschler Beteiligungs GmbH Nouveaux peptides et leur utilisation pour le traitement de l'oedème
AT506150B1 (de) * 2007-12-12 2010-01-15 Apeptico Forschung Und Entwick Zyklisches und cystein-freies peptid
AT506151B1 (de) 2007-12-12 2010-01-15 Apeptico Forschung Und Entwick Fusionsprotein
AT507953B1 (de) 2009-03-05 2011-02-15 Apeptico Forschung & Entwicklung Gmbh Verfahren zur vermeidung und zur behandlung einer hyperpermeabilität
AT509267A1 (de) 2010-01-14 2011-07-15 Apeptico Forschung & Entwicklung Gmbh Organische verbindungen zur regulierung von vektoriellen ionenkanälen
PL2397151T3 (pl) * 2010-06-21 2015-10-30 Apeptico Forschung & Entwicklung Gmbh Leczenie powikłań naczyniowych cukrzycy
AT510585B1 (de) * 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
US11161881B2 (en) * 2010-11-18 2021-11-02 Apeptico Forschung Und Entwicklung Gmbh Composition comprising a peptide and an inhibitor of viral neuraminidase
EP2679239A1 (fr) * 2012-06-28 2014-01-01 Apeptico Forschung und Entwicklung GmbH Composition pharmaceutique pour le traitement de la forme pulmonaire du mal d'altitude provoqué par le manque d'oxygène et la pression atmosphérique réduite
US12004506B2 (en) 2013-04-23 2024-06-11 Apeptico Forschung Und Entwicklung Gmbh Pharmaceutical composition comprising a cyclic peptide of formula X1-GQRETPEGAEAKPWY-X2 and use for extracorporeal lung treatment
EP2988769B1 (fr) * 2013-04-23 2020-05-27 APEPTICO Forschung und Entwicklung GmbH Traitement du poumon extracorporel avec un peptide cyclique de formule x1-gqretpegaeakpwy-x2
MX2016011881A (es) 2014-03-18 2016-12-05 Apeptico Forschung & Entwicklung Gmbh Medicamento de peptido en polvo seco.
CN110613838A (zh) * 2018-06-19 2019-12-27 姜石松 增强细胞通透性的多肽及其应用
DK4051307T5 (da) 2020-05-08 2024-07-22 Apeptico Forschung & Entwicklung Gmbh Peptid til forebyggelse eller behandling af covid-19

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE384179C (de) * 1921-04-07 1923-10-27 Ludwig Weil Dr Laufrad fuer Kreiselpumpen und -geblaese
DE3841759A1 (de) 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
US5891679A (en) 1993-02-03 1999-04-06 N.V. Innogenetics S.A. TNF-alpha muteins and a process for preparing them
CN1181886C (zh) 1998-08-14 2004-12-29 基因创新有限公司 Tnf来源的肽在治疗水肿中的应用

Also Published As

Publication number Publication date
HU227661B1 (hu) 2011-10-28
HK1051805A1 (en) 2003-08-22
US20030185791A1 (en) 2003-10-02
EP1264599A1 (fr) 2002-12-11
CZ2001538A3 (cs) 2001-08-15
EP1247531A3 (fr) 2002-12-18
IL141064A (en) 2009-09-01
CN1181886C (zh) 2004-12-29
US7258861B2 (en) 2007-08-21
HUP0103117A2 (hu) 2001-12-28
ES2296872T3 (es) 2008-05-01
US20030105021A1 (en) 2003-06-05
CN1312724A (zh) 2001-09-12
EP1264599B1 (fr) 2007-09-26
DE69937206T2 (de) 2008-06-19
ZA200100656B (en) 2005-06-29
EP1247531A2 (fr) 2002-10-09
DE69937206D1 (de) 2007-11-08
ATE374039T1 (de) 2007-10-15
BR9912899A (pt) 2001-05-08
AU5620999A (en) 2000-03-06
CA2334941A1 (fr) 2000-02-24
NZ509604A (en) 2003-05-30
WO2000009149A1 (fr) 2000-02-24
PL203706B1 (pl) 2009-11-30
ATE395072T1 (de) 2008-05-15
EP1105152A1 (fr) 2001-06-13
JP2002522508A (ja) 2002-07-23
DK1264599T3 (da) 2008-02-04
PL345997A1 (en) 2002-01-14
HUP0103117A3 (en) 2004-03-01
AU764992B2 (en) 2003-09-04
EP1247531B1 (fr) 2008-05-14
CZ302862B6 (cs) 2011-12-21
JP4542266B2 (ja) 2010-09-08
TR200100338T2 (tr) 2001-12-21
CA2334941C (fr) 2011-08-09
PT1264599E (pt) 2008-01-07
DE69938743D1 (de) 2008-06-26

Similar Documents

Publication Publication Date Title
HK1051805A1 (en) Tnf-derivd peptides for use in treating oedema
WO2003044053A3 (fr) Peptides servant a traiter des tumeurs ou d'autres etats necessitant la suppression ou la destruction de cellules
WO2003008443A3 (fr) Peptides efficaces dans le traitement de tumeurs et d'autres etats pathologiques necessitant l'ablation ou la destruction de cellules
HU902697D0 (en) Process for the enzymatic removal of the n-terminal sequence of proteins
MX9606013A (es) Lacasas purificadas de myceliophthora y acidos nucleicos que codifican para las mismas.
CA2184908A1 (fr) Cathepsine derivee d'osteoclaste humain
AU2672900A (en) Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
IL187907A0 (en) Analogues of glp-1 and uses thereof
IL143481A0 (en) Glp-1 analogues
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
JP2001520045A5 (fr)
WO2002015922A3 (fr) Nouvelles utilisations d'anticonvulsivants a base d'acides amines
DE60217326D1 (de) Von neurofilamentproteinen abgeleitete peptide und deren medizinische verwendung
GB2367061A (en) Peptides
AR002742A1 (es) Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn
GR3015817T3 (en) Substituted alpha-amino acids having pharmaceutical activity.
WO1997046686A3 (fr) Polypeptide apparente au facteur de necrose tumorale
ATE198987T1 (de) Behandlung von tropikalischer spastischer paresis mit peptide t
ATE310091T1 (de) Carboxypeptidasen aus aspergillus oryzae und diese kodierende nukleinsäuren
DE69524415D1 (de) UNGESPLEISSTE VARIANTEN DES gp350/220
GB9604518D0 (en) Novel compounds